Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand.
Arthritis Rheumatol
; 73(5): 896-897, 2021 05.
Article
in English
| MEDLINE | ID: covidwho-1121982
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Rheumatic Diseases
/
Antirheumatic Agents
/
Drug and Narcotic Control
/
COVID-19 Drug Treatment
/
Health Services Accessibility
/
Hydroxychloroquine
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
/
Oceania
Language:
English
Journal:
Arthritis Rheumatol
Year:
2021
Document Type:
Article
Affiliation country:
Art.41643
Similar
MEDLINE
...
LILACS
LIS